Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diuretics revisited--again.

Literature DB >> 11416698

Diuretics revisited--again.

M Moser.

Abstract

Entities: Chemical

Mesh：

Substances：
Diuretics

Year: 2001 PMID： 11416698 PMCID： PMC8099320 DOI： 10.1111/j.1524-6175.2001.00468.x

Source DB: PubMed Journal: J Clin Hypertens (Greenwich) ISSN： 1524-6175 Impact factor: 3.738

× No keyword cloud information.

33 in total

1. Cardiotoxicity and diuretics: much speculation--little substance.

Authors: G T McInnes; W W Yeo; L E Ramsay; M Moser
Journal: J Hypertens Date: 1992-04 Impact factor: 4.844

2. Who really determines your patients' prescriptions?

Authors: M Moser; M D Blaufox; E Freis; R W Gifford; W Kirkendall; H Langford; A Shapiro; S Sheps
Journal: JAMA Date: 1991 Jan 23-30 Impact factor: 56.272

3. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial.

Authors: N O Borhani; M Mercuri; P A Borhani; V M Buckalew; M Canossa-Terris; A A Carr; T Kappagoda; M V Rocco; H W Schnaper; J R Sowers; M G Bond
Journal: JAMA Date: 1996-09-11 Impact factor: 56.272

Review 4. Suppositions and speculations--their possible effects on treatment decisions in the management of hypertension.

Authors: M Moser
Journal: Am Heart J Date: 1989-12 Impact factor: 4.749

Review 5. Lipid abnormalities and diuretics.

Authors: M Moser
Journal: Am Fam Physician Date: 1989-10 Impact factor: 3.292

6. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

Authors: L Hansson; L H Lindholm; T Ekbom; B Dahlöf; J Lanke; B Scherstén; P O Wester; T Hedner; U de Faire
Journal: Lancet Date: 1999-11-20 Impact factor: 79.321

Review 3. Drugs that interrupt the renin-angiotensin system should be among the preferred initial drugs to treat hypertension.

Authors: Michael A Moore
Journal: J Clin Hypertens (Greenwich) Date: 2003 Mar-Apr Impact factor: 3.738

4. Results of the ALLHAT trial: is the debate about initial antihypertensive drug therapy over?

Authors: Marvin Moser
Journal: J Clin Hypertens (Greenwich) Date: 2003 Jan-Feb Impact factor: 3.738

Review 5. Rationale for combination therapy in the management of hypertension.

Authors: Marvin Moser
Journal: J Clin Hypertens (Greenwich) Date: 2003 Nov-Dec Impact factor: 3.738

5 in total

Diuretics revisited--again.

1. Cardiotoxicity and diuretics: much speculation--little substance.

2. Who really determines your patients' prescriptions?

3. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial.

Review 4. Suppositions and speculations--their possible effects on treatment decisions in the management of hypertension.

Review 5. Lipid abnormalities and diuretics.

6. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

Review 7. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease.

8. Diuretic therapy and the risk of cardiac arrest.

9. Diuretic-induced ventricular ectopic activity.

10. Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus.

1. The more things change, the more they remain the same.

2. Low-dose combination therapy: why include a diuretic?

Review 3. Drugs that interrupt the renin-angiotensin system should be among the preferred initial drugs to treat hypertension.

4. Results of the ALLHAT trial: is the debate about initial antihypertensive drug therapy over?

Review 5. Rationale for combination therapy in the management of hypertension.